Abingdon Health Plc (LON:ABDX – Get Free Report) was down 2.6% during mid-day trading on Thursday . The company traded as low as GBX 9.50 and last traded at GBX 9.50. Approximately 5,535 shares were traded during trading, a decline of 98% from the average daily volume of 281,822 shares. The stock had previously closed at GBX 9.75.
Abingdon Health Stock Performance
The company has a quick ratio of 1.96, a current ratio of 1.91 and a debt-to-equity ratio of 15.05. The company has a 50 day moving average of GBX 11.29 and a 200 day moving average of GBX 8.79. The firm has a market cap of £23.85 million, a price-to-earnings ratio of -11.73 and a beta of 0.16.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Further Reading
- Five stocks we like better than Abingdon Health
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
